MARKER THERAPEUTICS, INC. Management Fee Expense
MARKER THERAPEUTICS, INC. (MRKR) reported Management Fee Expense of $15.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ManagementFeeExpense · last filed 2015-04-15
- MARKER THERAPEUTICS, INC. management fee expense for the quarter ending 2014-12-31 was -$78.75K.
- MARKER THERAPEUTICS, INC. management fee expense for the quarter ending 2014-09-30 was $41.25K, a 33.73% decline year-over-year.
- MARKER THERAPEUTICS, INC. management fee expense for the quarter ending 2013-12-31 was -$74.64K.
- MARKER THERAPEUTICS, INC. management fee expense for the quarter ending 2013-09-30 was $62.25K.
- MARKER THERAPEUTICS, INC. management fee expense for fiscal 2014 was $15.00K, a 88.64% decline from fiscal 2013.
- MARKER THERAPEUTICS, INC. management fee expense for fiscal 2013 was $132.09K.
| Period end | Management Fee Expense 3 month | Management Fee Expense 6 month | Management Fee Expense 9 month | Management Fee Expense 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$78.75K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | -$37.50K derived: sum of 2 quarters · filed 2015-04-15 | $15.00K 10-K · filed 2015-04-15 | |
| 2014-09-30 | $41.25K 10-Q · filed 2014-11-19 | $93.75K 10-Q · filed 2014-11-19 | ||
| 2014-06-30 | $3.75K 10-Q · filed 2014-08-18 | |||
| 2013-12-31 | -$74.64K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | -$12.40K derived: sum of 2 quarters · filed 2015-04-15 | $132.09K 10-K · filed 2015-04-15 | |
| 2013-09-30 | $62.25K 10-Q · filed 2014-11-19 | $206.74K 10-Q · filed 2014-11-19 | ||
| 2013-06-30 | $29.89K 10-Q · filed 2014-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |